In summary, the distinct expression pattern, transcriptional profile, involvement in ca, as well as interaction with cancer stem cells, present a fresh perspective for targeted molecular therapy of SIX1 in breast cancer patients and offer leads and insights towards a deeper understanding of the molecular mechanisms driving breast cancer tumorigenesis. This evidence concerns the gene SIX1 and breast carcinoma.